why choose us

First received: December 7, 2022

Clinical Trial: Adipose-derived Stromal Vascular Fraction Cells to Treat Parkinson

Study Status: Completed

Recruit Status: Completed

Condition: Idiopathic Parkinson Disease
Parkinson's Disease and Parkinsonism

Study Type: Interventional


Official Title: Treatment of Parkinson Disease With Transplantation of SVF Cells of Adipose Origin: Safety and Exploratory Efficacy Study

Brief Summary: This is an interventional study to treat 10 patients with a diagnosis of Parkinson's disease with neurological assessment from the Oxford Parkinson's Disease Quotient-39 (PDQ-39) and Movement Disorders Society Universal Parkinson's Disease Rating Scale (MDS-UPDRS), with autologous adipose tissue-derived stromal vascular fraction (SVF) cells by subdermal plane injection into the submuscular aponeurotic fascia of the face.This study assesses: 1) safety and 2) feasibility and 3) exploratory evidence of efficacy.

Read more